Company Profile · Healthcare

China Resources Sanjiu Medical & Pharmaceutical Co Ltd

000999 · Shenzhen
Country
China
IPO date
Nov 11, 1999
Employees
30,304
Buffett Score
80/100
Elite
Market capCN¥40.26B
Revenue (TTM)CN¥31.81B
EBITDACN¥5.32B
Profit margin10.3%
ROE10.3%
P/E (TTM)12.28
Forward P/E16.47
PEG1.38
EPSCN¥1.97
Dividend yield4.29%
52-week rangeCN¥21.60 – CN¥29.90

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chinese medicine health products; and vitamins, minerals, protein powder, collagen, probiotics, health foods, and formula granules. It also provides related health services. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. was incorporated in 1999 and is headquartered in Shenzhen, China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources Pharmaceutical Group Limited.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.

No reports on this stock in your language yet.